Ftse Mib
34.600,00
-0,65%
DAX
18.726,76
-0,21%
S&P 500
5.311,51
0,06%
NASDAQ
16.786,73
-0,05%
Bitcoin
69.773,97
-2,34%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adagio Therapeutics Inc (ADGI) Adagio Therapeutics Inc (ADGI) Notizie

ADGI

Adagio Therapeutics (ADGI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADGI
DataOraFonteTitoloSimboloCompagnia
29/06/202313:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADGIAdagio Therapeutics Inc
26/05/202300:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADGIAdagio Therapeutics Inc
12/04/202322:47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202322:20Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202322:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADGIAdagio Therapeutics Inc
10/04/202322:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADGIAdagio Therapeutics Inc
31/03/202322:38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADGIAdagio Therapeutics Inc
23/03/202321:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADGIAdagio Therapeutics Inc
09/02/202317:48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADGIAdagio Therapeutics Inc
19/12/202213:00GlobeNewswire Inc.Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA WorkshopNASDAQ:ADGIAdagio Therapeutics Inc
06/12/202222:01GlobeNewswire Inc.Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical OfficerNASDAQ:ADGIAdagio Therapeutics Inc
29/11/202223:17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADGIAdagio Therapeutics Inc
10/11/202222:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADGIAdagio Therapeutics Inc
06/10/202212:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADGIAdagio Therapeutics Inc
12/09/202213:15GlobeNewswire Inc.Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron VariantsNASDAQ:ADGIAdagio Therapeutics Inc
12/09/202213:00GlobeNewswire Inc.Adagio Therapeutics Announces Corporate Name Change to InvivydNASDAQ:ADGIAdagio Therapeutics Inc
06/09/202222:01GlobeNewswire Inc.Adagio Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:ADGIAdagio Therapeutics Inc
19/08/202223:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADGIAdagio Therapeutics Inc
15/08/202212:30GlobeNewswire Inc.Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business HighlightsNASDAQ:ADGIAdagio Therapeutics Inc
05/07/202214:00Business WireMithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy CampaignNASDAQ:ADGIAdagio Therapeutics Inc
05/07/202213:25GlobeNewswire Inc.Adagio Announces David Hering Named Permanent Chief Executive Officer and DirectorNASDAQ:ADGIAdagio Therapeutics Inc
01/07/202212:30GlobeNewswire Inc.Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of DirectorsNASDAQ:ADGIAdagio Therapeutics Inc
06/06/202212:03Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADGIAdagio Therapeutics Inc
02/06/202222:25Edgar (US Regulatory)Information Statement - Contested Solicitations (definitive) (defc14c)NASDAQ:ADGIAdagio Therapeutics Inc
19/05/202223:07Edgar (US Regulatory)Information Statement - Contested Solicitations (preliminary) (prec14c)NASDAQ:ADGIAdagio Therapeutics Inc
19/05/202222:31ValueWalkAdagio Therapeutics Jumps 629 Ranks To 119th Most Owned Stock On The PlatformNASDAQ:ADGIAdagio Therapeutics Inc
17/05/202214:45TipRanksAdagio Therapeutics (ADGI) Gets a Sell Rating from Morgan StanleyNASDAQ:ADGIAdagio Therapeutics Inc
13/05/202216:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADGIAdagio Therapeutics Inc
13/05/202212:30GlobeNewswire Inc.Adagio Therapeutics Reports First Quarter 2022 Financial ResultsNASDAQ:ADGIAdagio Therapeutics Inc
29/04/202223:22Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADGIAdagio Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADGI

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
G
Generali
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network